Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 2740
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
70886
LOL - That's about PAR for the course. Don't know
NotRichYet2
11/15/2021 11:21:58 AM
70885
He's a Big Pharma insider who will continue
(2)
Drano
11/15/2021 11:07:27 AM
Newer
Older
Recent Articles
Rekindling Historical Awareness Against Antisemitic Violence
LG Display Innovates with Revolutionary Stretchable Display
Discovering the Natural Beauty of China Through Student Eyes
Understanding Life in China: A Student's Perspective
Exploring Opportunities Through High-Quality Development
New Fortress Energy: Timeline for Investors' Legal Actions
ALK Teams Up with ARS Pharma to Launch Neffy® for Anaphylaxis
Celebrating Achievements at the Latest Monumental Marathon Event
Fate Therapeutics Showcases Innovative CAR T-cell Candidate for Cancer
Harnessing Ciforadenant's Promise in Prostate Cancer Immunotherapy
CloudOne Digital Welcomes Zach Smith to Propel Cloud Strategies
Replimune Showcases Promising Clinical Results for RP1 Drug
Universal Music Group Clarifies Recent Shareholder Comments
Marengo's Invikafusp Alfa Shows Promise in Advanced Cancer Trials
Insights on UMG's Stance Regarding US Listing Queries
Investors Explore Lilium N.V. Opportunities Amid Legal Actions
Kessler Topaz Calls Medpace Holdings Investors to Action
Ultragenyx Shares Progress on GTX-102 for Angelman Syndrome
Exodus Movement Set to Share Q3 Financial Results Soon
CSX Corporation Faces Investigation: Investors Urged to Act
Guayakí Yerba Mate Earns 2024 Good Housekeeping Award Recognition
Investigation into PACS Group: What Investors Should Know
Bruvi's Groundbreaking Brewer Wins Prestigious Award
MGP Ingredients Faces Scrutiny: Investors Urged to Act Now
Is Bitcoin Still the Best Cryptocurrency in 2024
Exploring the Vision of Global Art at Shanghai's Major Event
Sapience Therapeutics Highlights Innovative Cancer Treatments
Clay Cooley Auto Group Expands Operations with New Dealership
Clay Cooley Auto Group Expands with New Ford Dealership
BC.GAME Unveils Exciting Airdrop for Polymarket Participants
Join the 2024 CCHIO to Explore Innovations in Cancer Care
Iris Energy Limited Investors: Your Chance for Justice
TD Bank Investors Can Join Class Action for Recovery
Acadia Healthcare Faces Class Action as Legal Action Intensifies
GoldHaven's Strategic Acquisition Enhances Mining Portfolio
Key Insights on TMC the Metals Company's Class Action Lawsuit
EngageSmart Shareholders Urged to Act Before Critical Deadline
Updates on Acadia Healthcare: What Investors Need to Know
Class Action Alert for Toronto-Dominion Bank Shareholders
VERSES AI Inc. Finalizes First Phase of LIFE Private Placement
Lilium N.V. Faces Class Action Lawsuit Amid Financial Woes
Franklin Resources, Inc. Investigated for Possible Securities Misconduct
VERSES AI Inc. Expands Special Warrant Offering Plans
CIIE Event Showcases Global Trade Opportunities and Vision
CenterPoint Energy's Strategy to Alleviate Storm Cost for Customers
Silver Star Properties Set for Annual Shareholder Meeting
Investors Urged to Join Class Action Against Winnebago Industries
Kaspi.kz Investors: Take Action on Potential Misleading Claims
CenterPoint Energy Advances Resilience Initiatives for 2025
Keg Royalties Fund Declares November Cash Distribution